Gut bacteria diversity, digestive health, probiotics, prebiotics, and the gut-brain axis
396 articles
A newly identified defense system called ARMADA connects previously separate bacterial antiviral immune networks, revealing how microbes fight off viruses.
A formal correction notice has been issued for the 2025 IMPACT BCN trial subanalysis examining Mediterranean diet and Mindfulness-Based Stress Reduction effects on maternal microbiota during pregnancy.
New research questions whether long-term HBIG therapy is necessary after liver transplantation, potentially simplifying post-transplant care.
New research reveals how the gut's portal blood environment primes neutrophils to drive inflammation and damage in remote organs.
New research in Cell Metabolism explores how gut bacteria and their metabolites regulate immune checkpoint blockade efficacy in cancer patients.
A 12-month RCT finds a lactobacilli probiotic not only failed to prevent bone loss but accelerated it slightly vs. placebo.
A primate single-nucleus study identifies NCoR1 decline as a conserved gut aging mechanism — and shows metformin can restore it.
WES identified a genetic diagnosis in nearly 1 in 4 adults with unexplained cholestatic liver disease, including genes beyond the classic PFIC spectrum.
A completed pilot trial explores whether a cholesterol-lowering probiotic can improve cardiometabolic health in people with celiac disease.
A cradle-to-grave life cycle assessment finds reusable duodenoscopes may be the greener choice for ERCP procedures in Germany.
A microbiota-derived short-chain fatty acid stops Candida colonization by acidifying fungal cells — a finding with major implications for immunocompromised patients.
New research reveals how microbiota-produced SCFAs directly block Candida albicans growth, pointing to prebiotic therapies for immunocompromised patients.
